Concepedia

Jingyue Yao

JY

Statistics

Publications

6

Citations

533

H-Index

6

Active since

2017

Affiliations

State Key Laboratory of Natural Medicine(Current)

China Pharmaceutical University

Nanjing University of Chinese Medicine

Jingyue Yao is an author at State Key Laboratory of Natural Medicine specializing in cell death, medicine, and cancer research.

Top concepts

Publications per year

2017–2021

6

Publications

6

CDK9 inhibition blocks the initiation of PINK1-PRKN-mediated mitophagy by regulating the SIRT1-FOXO3-BNIP3 axis and enhances the therapeutic effects involving mitochondrial dysfunction in hepatocellular carcinoma

Jingyue Yao, Jubo Wang, Ye Xu et al. · Autophagy · 2021 · 233 citations · Full text

Oroxylin A suppresses the development and growth of colorectal cancer through reprogram of HIF1α-modulated fatty acid metabolism

Ting Ni, Zihao He, Yuanyuan Dai et al. · Cell Death and Disease · 2017 · 87 citations · Full text

Regulation of AMPK-related glycolipid metabolism imbalances redox homeostasis and inhibits anchorage independent growth in human breast cancer cells

Lin Yang, Zihao He, Jingyue Yao et al. · Redox Biology · 2018 · 77 citations · Full text

RETRACTED ARTICLE: Oroxylin A activates PKM1/HNF4 alpha to induce hepatoma differentiation and block cancer progression

Libin Wei, Yuanyuan Dai, Yuxin Zhou et al. · Cell Death and Disease · 2017 · 70 citations · Full text

Novel CDK9 inhibitor oroxylin A promotes wild-type P53 stability and prevents hepatocellular carcinoma progression by disrupting both MDM2 and SIRT1 signaling

Jingyue Yao, Shu Xu, Yuening Sun et al. · Acta Pharmacologica Sinica · 2021 · 50 citations · Full text

, , +5

Rows per page

1–5 of 6